» Articles » PMID: 189497

Nuclear Preparations of SV40-transformed Cells Contain Tumor-specific Transplantation Antigen Activity

Overview
Journal Virology
Specialty Microbiology
Date 1977 Jan 1
PMID 189497
Citations 25
Authors
Affiliations
Soon will be listed here.
Citing Articles

Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen.

Xie Y, Hwang C, Overwijk W, Zeng Z, Eng M, Mule J J Natl Cancer Inst. 1999; 91(2):169-75.

PMID: 9923859 PMC: 2249695. DOI: 10.1093/jnci/91.2.169.


Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.

Shearer M, Bright R, Lanford R, Kennedy R Clin Exp Immunol. 1993; 91(2):266-71.

PMID: 7679059 PMC: 1554672. DOI: 10.1111/j.1365-2249.1993.tb05893.x.


Dynamic nature of the association of large tumor antigen and p53 cellular protein with the surfaces of simian virus 40-transformed cells.

Santos M, Butel J J Virol. 1984; 49(1):50-6.

PMID: 6690721 PMC: 255423. DOI: 10.1128/JVI.49.1.50-56.1984.


The immunopathology of SV40-induced transformation.

Mora P Springer Semin Immunopathol. 1982; 5(1):7-32.

PMID: 6314571 DOI: 10.1007/BF00201954.


Construction and characterization of viable deletion mutants of simian virus 40 lacking sequences near the 3' end of the early region.

Cole C J Virol. 1982; 43(2):489-502.

PMID: 6287029 PMC: 256152. DOI: 10.1128/JVI.43.2.489-502.1982.